
QIAGEN N.V. QGEN
Geschäftsbericht 2024
hinzugefügt 14.03.2026
QIAGEN N.V. EBITDA per Share 2011-2026 | QGEN
EBITDA per Share Jährlich QIAGEN N.V.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.35 | 2.7 | 3.25 | 3.71 | 2.59 | 0.91 | 2.09 | 1.62 | 0.611 | 0.955 | 0.886 | 0.439 | 0.912 | 0.56 |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 3.71 | 0.439 | 1.61 |
EBITDA per Share anderer Aktien in der Diagnostik & Forschung
| Name | EBITDA per Share | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
-0.94 | - | -6.23 % | $ 30.6 M | ||
|
ICON Public Limited Company
ICLR
|
19.2 | $ 98.33 | 0.9 % | $ 8.11 B | ||
|
Akumin
AKU
|
0.78 | - | -17.87 % | $ 25.9 M | ||
|
Aspira Women's Health
AWH
|
-0.28 | - | -6.19 % | $ 10.5 M | ||
|
Brainsway Ltd.
BWAY
|
-0.16 | $ 13.71 | -0.22 % | $ 99.4 M | ||
|
Charles River Laboratories International
CRL
|
8.64 | $ 155.46 | 1.83 % | $ 7.71 B | ||
|
Bioventus
BVS
|
1.52 | $ 8.62 | 0.23 % | $ 574 M | ||
|
DexCom
DXCM
|
2.98 | $ 64.24 | -1.56 % | $ 25.1 B | ||
|
Oxford Immunotec Global PLC
OXFD
|
0.00122 | - | - | $ 562 M | ||
|
Castle Biosciences
CSTL
|
0.89 | $ 25.56 | 0.95 % | $ 710 M | ||
|
CareDx, Inc
CDNA
|
-0.3 | $ 17.01 | 3.4 % | $ 906 M | ||
|
Accelerate Diagnostics
AXDX
|
-0.15 | - | -61.36 % | $ 2.46 M | ||
|
Exact Sciences Corporation
EXAS
|
-0.43 | $ 103.57 | 0.29 % | $ 19.5 B | ||
|
Guardant Health
GH
|
-3.17 | $ 85.49 | 1.75 % | $ 10.7 B | ||
|
Global Cord Blood Corporation
CO
|
5.37 | - | - | $ 399 M | ||
|
Genetic Technologies Limited
GENE
|
-1.27 | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
-1.12 | - | 0.12 % | $ 80.1 M | ||
|
Fulgent Genetics
FLGT
|
-1.62 | $ 14.77 | 0.61 % | $ 447 M | ||
|
PRA Health Sciences, Inc.
PRAH
|
8.68 | - | - | $ 10.7 B | ||
|
Biodesix
BDSX
|
-0.22 | $ 17.88 | -6.63 % | $ 2.32 B | ||
|
Anixa Biosciences
ANIX
|
-361 | $ 2.83 | -1.05 % | $ 91.8 K | ||
|
Danaher Corporation
DHR
|
7.63 | $ 187.32 | 0.57 % | $ 134 B | ||
|
IQVIA Holdings
IQV
|
19.4 | $ 164.72 | 1.1 % | $ 28.3 B | ||
|
Biocept
BIOC
|
-1.79 | - | -13.05 % | $ 7.29 M | ||
|
Heska Corporation
HSKA
|
-0.61 | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
-22.8 | - | -20.0 % | $ 1.06 M | ||
|
Illumina
ILMN
|
-3.01 | $ 118.94 | 2.92 % | $ 18.9 B | ||
|
Quest Diagnostics Incorporated
DGX
|
19.1 | $ 199.7 | -0.46 % | $ 22.2 B | ||
|
Agilent Technologies
A
|
5.49 | $ 111.51 | -0.06 % | $ 33.9 B | ||
|
BioNano Genomics
BNGO
|
-70.8 | $ 1.11 | -0.89 % | $ 1.41 M | ||
|
DarioHealth Corp.
DRIO
|
-1.96 | $ 9.0 | -0.99 % | $ 255 M | ||
|
Neogen Corporation
NEOG
|
-4.34 | $ 9.09 | -2.78 % | $ 1.97 B | ||
|
National Research Corporation
NRC
|
1.35 | $ 16.52 | 0.12 % | $ 370 M | ||
|
Chembio Diagnostics
CEMI
|
-0.65 | - | 0.22 % | $ 16.8 M | ||
|
Check-Cap Ltd.
CHEK
|
-4.41 | - | - | $ 9.42 M | ||
|
Pacific Biosciences of California
PACB
|
-1.8 | $ 1.33 | 4.72 % | $ 399 M | ||
|
Co-Diagnostics
CODX
|
-1.41 | - | - | $ 79.8 M | ||
|
Medpace Holdings
MEDP
|
19.5 | $ 450.41 | 1.48 % | $ 13 B | ||
|
Celcuity
CELC
|
-2.87 | $ 114.22 | 3.11 % | $ 4.51 B | ||
|
DermTech
DMTK
|
-3.17 | - | -11.32 % | $ 2.94 M | ||
|
Mettler-Toledo International
MTD
|
2.48 | $ 1 173.74 | 0.49 % | $ 24.2 B | ||
|
Personalis
PSNL
|
-0.97 | $ 6.72 | 1.97 % | $ 398 M | ||
|
NeoGenomics
NEO
|
-0.62 | $ 7.88 | -1.25 % | $ 1.01 B | ||
|
Enzo Biochem
ENZ
|
-218 | - | -8.98 % | $ 14.8 K | ||
|
Natera
NTRA
|
-5.33 | $ 187.85 | -1.29 % | $ 18.5 B | ||
|
Sotera Health Company
SHC
|
0.33 | $ 13.42 | 0.71 % | $ 3.81 B | ||
|
Invitae Corporation
NVTA
|
0.2 | - | - | $ 21.2 M | ||
|
OPKO Health
OPK
|
-0.08 | $ 1.19 | 2.59 % | $ 826 M |